TWO:7561

Bioray Biotech Co., Ltd · TWO · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 12:49 UTC

Last close

n/aTWD

Market data

14.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
14.5%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
32.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.31x

5.28x

-9.19x

0.83x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.31x
Its own average over 9 years, 169.8M.
Profit5.28x
Its own average over 9 years, 6.1M.
Free cash flow-9.19x
Its own average over 9 years, -7.8M.
Debt0.83x
Its own average over 8 years, 55.8M.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -9.19 times.

Sales is 1.31 times its own 9-year average; Profit is 5.28 times its own 9-year average; Free cash flow is -9.19 times its own 9-year average; Debt is 0.83 times its own 8-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 9-year average1.31
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Profit against its own 9-year average5.28
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Free cash flow against its own 9-year average-9.19
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Debt against its own 8-year average0.83
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
TWD